Skip to main content Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
Nov 08, 2019 7:00am EST

Recro Pharma Reports Third Quarter 2019 Financial Results

Nov 05, 2019 4:05pm EST

Recro Pharma to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 8, 2019

Nov 05, 2019 7:00am EST

Recro Pharma’s Board of Directors Approves Separation of Acute Care Business Segment and Declares Special Dividend Distribution of Baudax Bio Common Stock

Oct 31, 2019 7:00am EDT

FDA Grants Appeal to Recro Pharma for IV Meloxicam New Drug Application

Aug 08, 2019 7:14am EDT

Recro Pharma Reports Second Quarter 2019 Financial Results

Aug 01, 2019 7:00am EDT

Recro Pharma to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019

May 30, 2019 7:00am EDT

Recro Pharma to Present at Upcoming Investor Conferences

May 10, 2019 7:00am EDT

Recro Pharma Reports First Quarter 2019 Financial Results

May 06, 2019 7:00am EDT

Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019

Apr 16, 2019 7:00am EDT

Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • …
  • Page 24
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2023 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us